tiprankstipranks
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market
4512
Wakamoto Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4512 full AI Analyst Report?

Wakamoto Pharmaceutical Co., Ltd. (4512) Revenue

0 Followers
StatisticsMarket CapRevenue

Wakamoto Pharmaceutical Co., Ltd. Revenue

Wakamoto Pharmaceutical Co., Ltd. had a revenue of 1.97B in the quarter ending Dec 31, 2023, with 11.94%. This bring the company's revenue in the last twelve months to 7.98B, Increased -3.39%. In the fiscal year ending Mar 31, 2026, Wakamoto Pharmaceutical Co., Ltd. had annual revenue of 9.91B with 27.18% growth.
Revenue (ttm)
7.98B
Revenue Growth
27.18%
P/S Ratio
0.97
Revenue/Employee
¥32,695,845
Employees
303
Market Cap
¥9.61B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
9.91B2.12B+27.18%
Mar 31, 2025
7.79B51.04M+0.66%
Mar 31, 2024
7.74B-921.95M-10.65%
Mar 31, 2023
8.66B277.23M+3.31%
Mar 31, 2022
8.38B-511.69M-5.75%
Mar 31, 2021
8.89B-2.02B-18.53%
Mar 31, 2020
10.92B175.92M+1.64%
Mar 31, 2019
10.74B-158.90M-1.46%
Mar 31, 2018
10.90B――